Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pan-Chyr Yang

Showing results (411-420 of 495) with videos related to

Pageof 50
Sort By:
European Journal of Medicinal Chemistry|August 17, 2019
4(1H)-quinolone derivatives overcome acquired resistance to anti-microtubule agents by targeting the colchicine site of β-tubulinMing-Shiu Lin, Tse-Ming Hong, Ting-Hung Chou, et al.
Proceedings of the American Thoracic Society|September 20, 2011
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: international multidisciplinary classification of lung adenocarcinoma: executive summaryWilliam D Travis, Elisabeth Brambilla, Masayuki Noguchi, et al.
Lung Cancer (Amsterdam, Netherlands)|September 1, 2023
Whole exome sequencing and MicroRNA profiling of lung adenocarcinoma identified risk prediction features for tumors at stage I and its substagesHao Ho, Sung-Liang Yu, Hsuan-Yu Chen, et al.
Nature Communications|February 25, 2014
Inhibition of miR-146a prevents enterovirus-induced death by restoring the production of type I interferonBing-Ching Ho, I-Shing Yu, Li-Fan Lu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 25, 2014
Bcl-2-like protein 11 deletion polymorphism predicts survival in advanced non-small-cell lung cancerJih-Hsiang Lee, Yu-Lin Lin, Wei-Hsun Hsu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 15, 2022
Expert Consensus Recommendations on Biomarker Testing in Metastatic and Nonmetastatic NSCLC in AsiaTetsuya Mitsudomi, Daniel Tan, James Chih-Hsin Yang, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2023
Upfront liquid next-generation sequencing in treatment-naïve advanced non-small cell lung cancer patients: A prospective randomised study in the Taiwanese health systemChing-Yao Yang, Jin-Yuan Shih, Wei-Yu Liao, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 25, 2015
Estrogen Receptor Gene Polymorphisms and Lung Adenocarcinoma Risk in Never-Smoking WomenKuan-Yu Chen, Chin-Fu Hsiao, Gee-Chen Chang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 30, 2008
Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemotherapy-naive non-small-cell lung cancer receiving first-line gefitinib monotherapyChih-Hsin Yang, Chong-Jen Yu, Jin-Yuan Shih, et al.
Journal of Medicinal Chemistry|March 4, 2020
Suppression of Drug-Resistant Non-Small-Cell Lung Cancer with Inhibitors Targeting Minichromosomal Maintenance ProteinChia-Yi Lin, Hsin-Yi Wu, Yuan-Ling Hsu, et al.
Pageof 50

Showing results (411-420 of 495) with videos related to

Sort By:
Pageof 50
European Journal of Medicinal Chemistry|August 17, 2019
4(1H)-quinolone derivatives overcome acquired resistance to anti-microtubule agents by targeting the colchicine site of β-tubulinMing-Shiu Lin, Tse-Ming Hong, Ting-Hung Chou, et al.
Proceedings of the American Thoracic Society|September 20, 2011
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: international multidisciplinary classification of lung adenocarcinoma: executive summaryWilliam D Travis, Elisabeth Brambilla, Masayuki Noguchi, et al.
Lung Cancer (Amsterdam, Netherlands)|September 1, 2023
Whole exome sequencing and MicroRNA profiling of lung adenocarcinoma identified risk prediction features for tumors at stage I and its substagesHao Ho, Sung-Liang Yu, Hsuan-Yu Chen, et al.
Nature Communications|February 25, 2014
Inhibition of miR-146a prevents enterovirus-induced death by restoring the production of type I interferonBing-Ching Ho, I-Shing Yu, Li-Fan Lu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 25, 2014
Bcl-2-like protein 11 deletion polymorphism predicts survival in advanced non-small-cell lung cancerJih-Hsiang Lee, Yu-Lin Lin, Wei-Hsun Hsu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 15, 2022
Expert Consensus Recommendations on Biomarker Testing in Metastatic and Nonmetastatic NSCLC in AsiaTetsuya Mitsudomi, Daniel Tan, James Chih-Hsin Yang, et al.
European Journal of Cancer (Oxford, England : 1990)|September 18, 2023
Upfront liquid next-generation sequencing in treatment-naïve advanced non-small cell lung cancer patients: A prospective randomised study in the Taiwanese health systemChing-Yao Yang, Jin-Yuan Shih, Wei-Yu Liao, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 25, 2015
Estrogen Receptor Gene Polymorphisms and Lung Adenocarcinoma Risk in Never-Smoking WomenKuan-Yu Chen, Chin-Fu Hsiao, Gee-Chen Chang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 30, 2008
Specific EGFR mutations predict treatment outcome of stage IIIB/IV patients with chemotherapy-naive non-small-cell lung cancer receiving first-line gefitinib monotherapyChih-Hsin Yang, Chong-Jen Yu, Jin-Yuan Shih, et al.
Journal of Medicinal Chemistry|March 4, 2020
Suppression of Drug-Resistant Non-Small-Cell Lung Cancer with Inhibitors Targeting Minichromosomal Maintenance ProteinChia-Yi Lin, Hsin-Yi Wu, Yuan-Ling Hsu, et al.
Pageof 50